ACMR — ACM Research Cashflow Statement
0.000.00%
- $2.63bn
- $2.23bn
- $901.31m
Annual cashflow statement for ACM Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 42.9 | 50.6 | 96.9 | 131 | 122 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.127 | 9.79 | 14.4 | 69 | 43.7 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -83.4 | -132 | -181 | -63.1 | -178 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -40.1 | -62.2 | -75.3 | 152 | -10.3 |
| Capital Expenditures | -9.71 | -92.5 | -64.3 | -85.9 | -57.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.57 | -173 | 57.6 | 74 | -333 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -11.3 | -266 | -6.75 | -12 | -390 |
| Financing Cash Flow Items | — | — | -3.95 | -6.9 | 616 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 539 | 45.9 | 18.5 | 92.5 | 742 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 491 | -315 | -65.3 | 228 | 355 |